Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Chelsea Therapeutics Careers

Chelsea Therapeutics Careers Newsletter

Nirogy Therapeutics Appoints Simon Pedder, Ph.D., as Chief Executive Officer 12 Jan 2022 12:30 GMT
… of CEO of Chelsea Therapeutics before that. Earlier in his career, Dr. Pedder … decade. Dr. Pedder began his career as a faculty member in …
Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company Announces Dr. Simon Pedder has Joined the Board 06 Jan 2022 16:11 GMT
… primarily through his career at Hoffmann-LaRoche and Chelsea Therapeutics. Dr Pedder … , President and CEO of Chelsea Therapeutics and Chief Business and Strategy … his experience building and selling Chelsea Therapeutics will help Voltron better position …
Cerecor Appoints Keith Schmidt to its Board of Directors 12 Jun 2019 20:05 GMT
… the Chief Commercial Officer of Chelsea Therapeutics International Ltd. prior to its … . Over the course of his career, Mr. Schmidt has worked for …
Cerecor Appoints Simon Pedder to its Board of Directors 09 Apr 2018 12:07 GMT
… cancer. Simon has a long career in drug development including recent … Biosciences, President and CEO of Chelsea Therapeutics, Vice President of Oncology Pharma …
Delcath Enhances Board of Directors With Appointment of Industry Veteran, Dr. Simon Pedder 20 Nov 2017 13:00 GMT
… a greater than 30-year career in drug development, has joined … of cancer. During his long career in drug development, Dr. Pedder … Biosciences, President and CEO of Chelsea Therapeutics, Executive Officer and Vice President …
Changes to Lundbeck’s Executive Management 30 Oct 2017 20:50 GMT
… Squibb Company. He began his career at Eli Lilly and Company … Lundbeck, including the acquisition of Chelsea Therapeutics in 2014 that added Northera …
Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer 07 Mar 2017 12:10 GMT
… as President and CEO of Chelsea Therapeutics, a publicly held biopharmaceutical company … capital firm. He began his career at Hoffmann-La Roche Inc …
OXiGENE Appoints Dr. Simon Pedder to Board of Directors 24 Mar 2016 12:30 GMT
… . Pedder has had a successful career in drug development and is … Cellectar Biosciences, Inc. and of Chelsea Therapeutics, Inc. Before joining the pharmaceutical …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS